# Long-Term Safety of Febuxostat in Subjects With Gout.

> **NCT00174941** · PHASE2 · COMPLETED · sponsor: **Takeda** · enrollment: 116 (actual)

## Conditions studied

- Gout

## Interventions

- **DRUG:** Febuxostat
- **DRUG:** Febuxostat
- **DRUG:** Febuxostat

## Key facts

- **NCT ID:** NCT00174941
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-03
- **Primary completion:** 2006-12
- **Final completion:** 2006-12
- **Target enrollment:** 116 (ACTUAL)
- **Last updated:** 2011-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00174941

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00174941, "Long-Term Safety of Febuxostat in Subjects With Gout.". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT00174941. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*